Gilead Joins First-of-its-Kind Public-Private Initiative to Improve Management of Viral Hepatitis in Vietnam and the PhilippinesBusiness Wire • 09/22/22
Gilead (GILD) Drugs Get Positive CHMP Opinion for Label ExpansionZacks Investment Research • 09/19/22
Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead's Veklury for severe diseaseMarket Watch • 09/16/22
8 Stocks in the Penalty Box That Offer Big Upside and Passive Income Dividends as High as 9%24/7 Wall Street • 09/16/22
Kite's CAR T-cell Therapy Yescarta® First in Europe to Receive Positive CHMP Opinion for Use in Second-line Diffuse Large B-cell Lymphoma and High-grade B-cell LymphomaBusiness Wire • 09/16/22
EU regulator recommends extending Gilead's COVID treatment Veklury for use in pediatric patientsMarket Watch • 09/16/22
CHMP Adopts Positive Opinion to Extend Indication of Veklury® (Remdesivir) for the Treatment of Pediatric Patients with COVID-19Business Wire • 09/16/22
WHO Expands Recommendation for Veklury® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 GuidelineBusiness Wire • 09/15/22
Gilead Sciences, Inc. (GILD) Presents at Baird 2022 Global Healthcare Conference (Transcript)Seeking Alpha • 09/14/22
Gilead Sciences, Inc. (GILD) Presents at Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/13/22
Gilead Foundation Awards $20 Million to Organizations Working to Advance Health Through Education EquityBusiness Wire • 09/13/22
7 Surprising Stocks With Fat Dividends That Offer Some Very Solid Inflation Protection24/7 Wall Street • 09/13/22
Gilead Sciences, Inc. (GILD) Presents at 2022 Wells Fargo Healthcare Conference - (Transcript)Seeking Alpha • 09/08/22
Trodelvy® Significantly Improved Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in TROPiCS-02 StudyBusiness Wire • 09/07/22